Anticoagulant therapy management of venous thromboembolism recurrence occurring during anticoagulant therapy: a descriptive study
- 23 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Thrombosis and Thrombolysis
- Vol. 52 (2), 414-418
- https://doi.org/10.1007/s11239-021-02377-8
Abstract
Limited evidence exists regarding management of recurrent venous thromboembolism (VTE) that occurs during anticoagulant therapy. We aimed to describe patieKeywords
This publication has 13 references indexed in Scilit:
- Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next?Thrombosis Research, 2019
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapyBlood, 2017
- Antithrombotic Therapy for VTE DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2016
- The epidemiology of venous thromboembolismJournal of Thrombosis and Thrombolysis, 2016
- Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosisJournal of Thrombosis and Haemostasis, 2015
- Economic burden of recurrent venous thromboembolism: Analysis from a U.S. hospital perspectiveAmerican Journal of Health-System Pharmacy, 2015
- Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patientsJournal of Thrombosis and Haemostasis, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosisBlood, 2002